Exelixis, Inc. (EXEL)
59.13
+0.60
(+1.03%)
USD |
NASDAQ |
Sep 03, 16:00
59.35
+0.22
(+0.37%)
After-Hours: 07:30
Exelixis Cash and Short Term Investments (Annual) : 1.059B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.059B |
| December 31, 2024 | 1.111B |
| December 31, 2023 | 995.30M |
| December 31, 2022 | 1.308B |
| December 31, 2021 | 1.467B |
| December 31, 2020 | 1.207B |
| December 31, 2019 | 852.24M |
| December 31, 2018 | 693.33M |
| December 31, 2017 | 388.28M |
| December 31, 2016 | 419.80M |
| December 31, 2015 | 167.06M |
| December 31, 2014 | 156.50M |
| December 31, 2013 | 254.67M |
| December 31, 2012 | 423.69M |
| December 31, 2011 | 194.26M |
| Date | Value |
|---|---|
| December 31, 2010 | 162.66M |
| December 31, 2009 | 203.09M |
| December 31, 2008 | 262.40M |
| December 31, 2007 | 271.54M |
| December 31, 2006 | 233.97M |
| December 31, 2005 | 197.82M |
| December 31, 2004 | 155.18M |
| December 31, 2003 | 237.59M |
| December 31, 2002 | 216.23M |
| December 31, 2001 | 227.70M |
| December 31, 2000 | 112.55M |
| December 31, 1999 | 115.52M |
| December 31, 1998 | 2.058M |
| December 31, 1997 | 9.715M |
| December 31, 1996 | 8.086M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.908B |
| BioMarin Pharmaceutical, Inc. | 1.561B |
| Cytokinetics, Inc. | 885.34M |
| Emergent BioSolutions, Inc. | 209.10M |
| Gilead Sciences, Inc. | 9.613B |